| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | -0.0096 | 0.8 |
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.0098 | 0.8 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0089 | 0.8 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.0089 | 0.8 |
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | 0.0084 | 0.8 |